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Abstract  The  possibility  to  obtain  DNA  from  smears  is  a  valuable  alternative  to  remedy  the
lack of  samples  when  they  are  totally  used  for  bacilloscopy;  this  technique  solves  the  biosafety
problem  related  to  a  possible  accident  with  the  transportation  of  ﬂasks  containing  potentially
transmissible  clinical  samples.  Hence,  the  purpose  of  this  study  was  to  utilize  the  insertion
sequence  IS6110  for  ampliﬁcation  of  DNA  from  a  smear-positive  sample  for  tuberculosis  (TB)
diagnosis.  Among  the  52  positive  bacilloscopies,  sensitivity,  speciﬁcity,  positive  predictive  value
and negative  predictive  value  were  52.3  %,  100  %,  100  %  and  89.7  %,  respectively  whereas  accu-
racy was  90.7  %.  The  IS6110-based  PCR  for  TB  diagnosis  developed  in  DNA  extracted  from  a
positive smear  is  a  fast,  simple,  speciﬁc,  and  safe  method.
© 2014  Asociación  Argentina  de  Microbiología.  Published  by  Elsevier  España,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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PCR  in  house  con  ADN  extraído  directamente  de  frotis  positivos  para  conﬁrmar  o
excluir  el  diagnóstico  de  tuberculosis:  enfoque  en  la  bioseguridad
Resumen  La  posibilidad  de  obtener  ADN  a  partir  de  frotis  es  una  valiosa  alternativa  para
Tuberculosis; remediar la  falta  de  muestras  cuando  estas  son  totalmente  utilizadas  para  la  baciloscopia;  esta
Bioseguridad opción soluciona,  además,  el  problema  de  bioseguridad  asociado  a  la  posibilidad  de  accidente
al transportar  frascos  que  contienen  muestras  clínicas  potencialmente  infectivas.  Por  lo  tanto,
el propósito  de  este  estudio  fue  utilizar  para  el  diagnóstico  de  la  tuberculosis  la  secuencia
de inserción  IS6110  para  ampliﬁcación  del  ADN  a  partir  de  frotis  que  resultaron  positivos  por
baciloscopia.  Del  análisis  de  52  baciloscopias  positivas  surge  que  la  sensibilidad,  la  especiﬁcidad,
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el  valor  predictivo  positivo  y  el  valor  predictivo  negativo  de  esta  técnica  fueron,  respectiva-
mente, del  52,3  %,  del  100  %,  del  100  %  y  del  89,7  %;  y  la  precisión  fue  del  90,7  %.  La  PCR  IS6110
para el  diagnóstico  de  tuberculosis,  desarrollada  con  ADN  extraído  de  frotis  positivos,  es  un
método  rápido,  simple,  especíﬁco  y  seguro.
© 2014  Asociación  Argentina  de  Microbiología.  Publicado  por  Elsevier  España,  S.L.U.  Este
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Tuberculosis  (TB)  continues  to  be  a  large  global  health
roblem.  In  2011,  there  were  84,137  notiﬁed  TB  cases
n  Brazil,  40,289  of  which  showed  positive-bacilloscopy,
ccounting  for  66  %  of  pulmonary  TB;  12,683  new  cases
resented  negative  bacilloscopy  ﬁndings,  and  10,067  were
xtrapulmonary  TB  cases.  In  view  of  such  data,  Brazil  cur-
ently  ranks  15th  on  the  list  of  22  countries  presenting
he  highest  TB  indexes  all  over  the  world12.  Nontubercu-
ous  Mycobacteria  (NTM)  also  have  the  capacity  to  cause
he  disease,  and  their  importance  is  progressively  grow-
ng  with  the  isolation  of  different  mycobacterial  species
n  the  laboratory.  The  clinical-laboratory  correlation  is  of
rucial  importance  for  the  diagnosis  and  determination  of
 therapeutic  strategy4.  Bacilloscopy  is  a  simple,  fast,  and
nexpensive  test,  being  the  most  commonly  used  technique
or  TB  diagnosis.  The  possibility  to  obtain  DNA  from  smears
s  a  valuable  alternative  to  remedy  the  lack  of  samples  when
hese  are  totally  utilized  for  bacilloscopy;  in  addition,  this
echnique  solves  the  biosafety  problem  related  to  the  trans-
ortation  of  ﬂasks  with  clinical  samples  that  are  potentially
ransmissible,  in  case  of  an  accident2,9,10.  The  ampliﬁca-
ion  of  nucleic  acids  by  means  of  PCR  directly  from  smears
as  been  described  by  some  authors  as  more  speciﬁc  with
espect  to  bacilloscopy  and  faster  than  culture  methods2,10.
ositive  bacilloscopy  does  not  differentiate  Mycobacterium
uberculosis  complex  (MTBC)  species  from  Nontuberculous
ycobacteria  (NTM)  ones;  however,  when  associated  to  PCR,
t  increases  the  accuracy  of  TB  diagnosis5,8.  The  goal  of  the
resent  study  is  to  use  the  insertion  sequence  IS6110  for
mpliﬁcation  of  DNA  from  smears  for  TB  diagnosis  and  to
xclude  it  when  the  smear  is  positive,  taking  biosafety  into
ccount.
Two  hundred  eighty-seven  smears  (convenience  sam-
les)  coming  from  the  Faculty  of  Medicine/Laboratory  of
esearch  of  Mycobacteria/University  Hospital  --  Federal  Uni-
ersity  of  Minas  Gerais  (Faculdade  de  Medicina/Laboratório
e  Pesquisa  em  Micobactérias/Hospital  das  Clínicas  Univer-
idade  Federal  de  Minas  Gerai  --  FM/LM/HC-UFMG)  were
elected  and  stained  by  the  Ziehl  Neelsen  and  Auramine
ethod,  along  the  period  between  2010  January  and  2011
ecember.  Only  those  smears  having  culture  results  were
ncluded.  Of  the  287  smears,  26  were  excluded  because
hey  did  not  meet  the  inclusion  criteria;  therefore  261
mears  remained.  Fifty-two  (52)  of  the  smears  presented
ositive  bacilloscopies  and  cultures  whereas  35  had  nega-
ive  bacilloscopies  and  positive  cultures  and  174  negative
acilloscopies  and  cultures.  Seventy-two  (72)  of  them  were
dentiﬁed  as  MTBC  and  15  as  NTM.  The  culture  was  devel-
ped  in  Löwenstein--Jensen  medium  and  the  identiﬁcation
est  used  phenotypic  methods6.  DNA  extraction  was  done
y  Chelex-100  +  Nonidet  P40  (NP40)  in  smear  where  a  vol-
me  of  25  l  of  Chelex  solution,  containing  5  %  Chelex-100,
 %  Nonidet  P40,  1  %  Tween  20,  and  distilled  water  was  added
a
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n  the  smear.  The  smear  was  scraped  off  with  the  help  of
 tip,  up  to  complete  removal;  then,  it  was  transferred
o  an  Eppendorf  tube  containing  75  l  of  the  same  solu-
ion.  After  stirring,  the  Eppendorf  tube  was  incubated  for
0  min  at  100 ◦C.  The  samples  were  centrifuged  for  10  min  at
3,000  ×  g;  then,  the  supernatant  was  transferred  to  a  new
terile  Eppendorf  tube  and  5  l of  the  solution  was  utilized
or  PCR1,10.
The  PCR  was  developed  under  the  following  conditions:
.0  l of  buffer  (10×),  3.0  l  of  50  mM  MgCl2, 0.2  l 25  mM
NTP,  10  pmol  of  every  oligonucleotide  (IS1-5′ CCT  GCG  AGC
TA  GGC  GTC  GG  3′ and  IS2-5′ CTC  GTC  CAG  CGC  CGC  TTC  GG
′),  and  0.5  l of  Taq  DNA  Polymerase  (500  U)  Invitrogen®,
n  a  ﬁnal  volume  of  50  l.  The  initial  DNA  denaturation
ccurred  at  94 ◦C  for  2  min,  and  after  a  total  of  40  cycles
f  94 ◦C  for  30  s,  68 ◦C  for  2  min,  71 ◦C  for  1  min,  and  a  ﬁnal
xtension  at  72 ◦C  for  10  min1.  The  amplicons  were  revealed
n  2  %  agarose  gel,  stained  by  ethidium  bromide.  The  ampli-
cations  were  developed  blindly.  Statistical  analysis:  the
esults  of  sensitivity  and  speciﬁcity,  the  positive  and  neg-
tive  predictive  values,  and  accuracy  were  compared  with
esults  of  culture  and  phenotypic  identiﬁcation  methods3,6.
rom  the  87  smears  with  positive  culture,  69  were  from
putum,  seven  from  bronchoalveolar  lavage  (BAL),  six  from
racheal  aspiration,  two  from  axillary  abscesses,  two  from
leural  liquids,  and  one  from  secretion  (abscess);  there  was
o  sensitivity  or  speciﬁcity  difference  among  these  samples
n  the  PCR  ampliﬁcation.  The  sensitivity  and  speciﬁcity  of
NA  ampliﬁcation  with  IS6110  were  37.5  and  100  %,  respec-
ively.  The  positive  predictive  value  (PPV)  was  100  %,  the
egative  predictive  value  (NPV)  80.8  %,  and  accuracy  was
2.8  %.  Among  the  22  negative  bacilloscopies  with  positive
ultures  of  MTB,  four  were  positive  by  PCR  (18  %).  Among
he  52  positive  bacilloscopies,  the  sensitivity,  speciﬁcity,
PV  and  NPV  were  52.3  %,  100  %,  100  %  and  89.7  %,  respec-
ively;  accuracy  was  90.7  %.  In  Fig.  1, the  electrophoresis
f  PCR  IS6110  ampliﬁcations  is  demonstrated.  The  possibil-
ty  of  obtaining  DNA  from  smears  is  a  valuable  alternative
o  solve  the  difﬁculties  in  transporting  biological  samples
long  distances  and  biosecurity),  and  excludes  the  diagnosis
f  tuberculosis  when  the  smear  is  positive  due  to  the  high
peciﬁcity  of  IS6110,  which  is  not  possible  when  only  stained
icroscopic  preparations  are  used2.
The  high  speciﬁcity  found  in  this  study  is  relevant,  as  it
voids  the  introduction  of  unnecessary  treatments  and  con-
ucts  in  the  cases  where  bacilloscopy  is  positive  and  an  NTM
nfection  is  in  course.  Therefore,  this  methodology  could  be
pplied  in  places  where  NTM  species  are  often  isolated,  such
s  in  Brazil,  for  instance,  where  during  the  period  between
000  and  2008,  a total  of  NTM  infection  cases  of  2139  were
eported.  Most  of  such  cases  were  notiﬁed  in  the  Southwest-
rn  region  (1458),  which  includes  the  State  of  Minas  Gerais,
here  this  study  was  developed.  The  remaining  cases  out  of
PCR  IS6110  for  diagnosis  
Figure  1  Electrophoresis  of  IS6110  PCR  ampliﬁcations.  Line  1
-- 100  bp  (bp  =  base  pair(s)  in  DNA)  DNA  ladder;  Line  2  --  negative
control;  Line  3  --  positive  control  --  M.  tuberculosis  H37RV;  Lines:
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13.Flores LL, Pai M, Colford JM, Riley LW. In-house acid ampliﬁcation4, 6,  8,  9,  and  10  --  NTM  samples;  Lines:  5,  7,  11,  and  13  --  MTB
samples;  Lines:  14  and  15  --  negative  samples.
this  total  were  distributed  among  the  Northern,  Southern,
Central-western,  and  Northeastern  regions  of  the  country11.
The  low  sensitivity  of  in-house  PCR  has  been  associated  with
the  small  amount  and  heterogeneity  of  bacilli  distribution
in  the  samples;  however,  an  increase  in  sensitivity  could  be
observed  when  the  bacilloscopies  were  positive,  which  is  in
accordance  with  prior  reports  in  the  literature11.  Although
in  this  study  the  IS6110  PCR  was  positive  in  only  four  sam-
ples  among  the  negative  bacilloscopies,  this  diagnosis  was
faster  than  the  culture,  which  presented  time  for  growth  as
a  limiting  factor2,7.  The  application  of  in-house  IS6110  PCR
in  DNA  extracted  from  smears  coming  from  several  sam-
ples  (BAL,  tracheal  aspiration  and  secretions)  is  described
herein  for  the  ﬁrst  time,  and  because  difference  has  not
been  observed  in  these  results,  this  methodology  has  also
applicative  potential  for  TB  diagnosis  in  other  clinical  spec-
imens.  The  handling  of  clinical  material  during  laboratory
procedures,  as  well  as  its  transportation,  could  generate
higher  risk  for  TB  transmission.  Hence,  the  possibility  of
using  PCR  in  smears  containing  bacilli  killed  in  the  previ-
ous  heat  ﬁxing  by  ﬂame  or  heat  plate  decreases  the  risk
related  to  such  transmission,  for  the  laboratory  profession-
als  who  will  conduct  the  DNA  extraction.  In  order  to  handle
the  mycobacteria  colonies,  a  more  complex  laboratory  is
necessary,  requiring  high  maintenance  investments  as  well
as  biosafety  level  III.  Therefore,  this  methodology  could  be
used  in  places  without  such  a  level  of  requirement,  as  is  the
case  in  several  places  in  Brazil  and  all  over  the  world;  in
addition,  of  course,  to  being  an  important  tool  for  TB  diag-
nosis  or  exclusion  it  when  the  smear  is  positive  in  cases  of
NTM  infection6,12.
In  conclusion,  the  IS6110  PCR  in  DNA  extracted  from  a
positive  smear  is  a  fast,  simple,  speciﬁc,  and  safe  method.
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